Healthcare professionals

We offer our patients new proven technology, advanced techniques and approved treatment protocols. Together these mean patients with cancer and heart disease achieve the best possible life outcomes.

Refer a patient

Refer a patient directly to one of our specialists in medical oncology, radiation therapy or theranostics.

Find out more

GenesisCare Research & Insights

Redefining the future of cancer care to improve patient outcomes

Find out more

Radiation oncology

We are at the forefront of the introduction of innovative and advanced radiation therapy techniques. 

Elekta Unity MR-Linac

Magnetic resonance image-guided radiation therapy, or MRIgRT, is the most exciting new development in advanced radiation therapy for years. MR-Linac technology places our team at the forefront of patient-centric cancer care.

DCISionRT®

DCISionRT is a molecular assay for women with ductal carcinoma in situ (DCIS), assessing the 10-year risk of recurrence or development of invasive breast cancer, and the benefit of radiation therapy in reducing that risk for your patients.

Compassionate Access Program for Prostate Cancer Patients

GenesisCare Australia offers many new and pioneering treatment options for all of its prostate cancer patients receiving radiotherapy. For patients without private health insurance however, some options are financially out of reach.   

Clinical CRO

A Contract Research Company that integrates with a Clinical Research Network into part of a healthcare company.

Theranostics

Partnering to unlock the full potential of theranostics.

Clinical trials

We’re dedicated to breaking boundaries through clinical studies and to finding new and improved ways to treat cancer that deliver better life outcomes for our patients.

Publications

Our expert physicians are involved in ground-breaking research across a range of specialties.

Multidiciplinary teams

Exceptional patient care is a collaboration of healthcare professionals who share our vision to ensure every patient receives world-class cancer care.

Latest updates